中国药业2017，Vol.26Issue(18)：1-4,4.DOI:10.3969/j.issn.1006-4931.2017.18.001
免疫抑制治疗患者乙型肝炎病毒再激活防治进展
Progress of Prevention and Treatment of Hepatitis B Virus Reactivation in Patients with Immunosuppressive Therapy
廖成成1
作者信息
- 1. 广西医科大学附属肿瘤医院,广西南宁 530021
- 折叠
摘要
Abstract
Objective To provide references and suggestions for the prevention and treatment of hepatitis B virus ( HBV ) reactivation in patients with immunosuppressive therapy. Methods The literatures about the diagnosis,high risk factors and therapeutic drug types of the patients with HBV reactivation with immunosuppressive therapy were reviewed. In accordance with the principles of stratified treatment systematically summarized the drug control strategies and disease monitoring methods. Results and Conclusion After immunosuppressive therapy,the patients prone to reactivation of HBV. Antiviral treatment of the start and end of the time,risk stratification and treatment of HBV activation in the monitoring of the relevant indicators is the key to prevention and control.关键词
乙型肝炎病毒/再激活/免疫抑制/防治/进展Key words
hepatitis B virus/reactivation/immunosuppression/prevention and treatment/progress分类
医药卫生引用本文复制引用
廖成成..免疫抑制治疗患者乙型肝炎病毒再激活防治进展[J].中国药业,2017,26(18):1-4,4.
